Export 91 results:
Filtres: Author is Roy, Marc-André  [Enlever les filtres]
S. Brodeur, Courteau, J., Vanasse, A., Courteau, M., Stip, E., Fleury, M. - J., Lesage, A., Demers, M. - F., Corbeil, O., Béchard, L., et Roy, M. - A., « Association between previous and future antipsychotic adherence in patients initiating clozapine: real-world observational study. », Br J Psychiatry, p. 1-8, 2022.
S. Brodeur, Vanasse, A., Courteau, J., Stip, E., Lesage, A., Fleury, M. - J., Courteau, M., et Roy, M. - A., « Comparative effectiveness and safety of antipsychotic drugs in patients with schizophrenia initiating or reinitiating treatment: A Real-World Observational Study. », Acta Psychiatr Scand, vol. 145, nᵒ 5, p. 456-468, 2022.
A. LeBlanc, Baron, M., Blouin, P., Tarabulsy, G., Routhier, F., Mercier, C., Després, J. - P., Hébert, M., De Koninck, Y., Cellard, C., Collin-Vézina, D., Côté, N., Dionne, É., Fleet, R., Gagné, M. - H., Isabelle, M., Lessard, L., Menear, M., Mérette, C., Ouellet, M. - C., Roy, M. - A., Saint-Jacques, M. - C., et Savard, C., « For a structured response to the psychosocial consequences of the restrictive measures imposed by the global COVID-19 health pandemic: the MAVIPAN longitudinal prospective cohort study protocol. », BMJ Open, vol. 12, nᵒ 4, p. e048749, 2022.
L. Béchard, Corbeil, O., Thivierge, M. - A., Assaad, I., Boulanger, C., Mailhot, M. - P., Turgeon-Fournier, A., Roy, M. - A., et Demers, M. - F., « Management of Rhabdomyolysis in a Patient Treated with Clozapine: A Case Report and Clinical Recommendations. », Clin Psychopharmacol Neurosci, vol. 20, nᵒ 1, p. 194-198, 2022.
A. M. Achim, Thibaudeau, É., Huot, A., Cellard, C., et Roy, M. - A., « What areas of everyday functioning are affected by theory of mind deficits in recent-onset schizophrenia spectrum disorders? », Early Interv Psychiatry, 2022.
M. - A. Roy et Abdel-Baki, A., Sante Ment Que, vol. 46, nᵒ 2, p. 19-21, 2021.
L. - D. Leclerc, Demers, M. - F., Bardell, A., Bilodeau, I., Williams, R., Tibbo, P., et M-A Roy, « A Chart Audit Study of Clozapine Utilization in Early Psychosis. », J Clin Psychopharmacol, vol. 41, nᵒ 3, p. 275-280, 2021.
L. Béchard, Corbeil, O., Plante, M., Thivierge, M. - A., Lafrenière, C. - É., M-A Roy, et Demers, M. - F., « Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series. », J Psychopharmacol, vol. 35, nᵒ 9, p. 1152-1157, 2021.
O. Corbeil, Bérubé, F. - A., Artaud, L., et Roy, M. - A., « [Detecting and Treating Comorbid Disorders in First-Episode Psychosis: A Lever for Recovery]. », Sante Ment Que, vol. 46, nᵒ 2, p. 307-330, 2021.
A. Malla, Roy, M. - A., Abdel-Baki, A., Conus, P., et McGorry, P., « [Early Intervention for Psychosis from Past to Future: Overcoming Implementation Challenges to Maximize its Impact?] », Sante Ment Que, vol. 46, nᵒ 2, p. 391-415, 2021.
M. - H. Morin, Bergeron, A. - S., Levasseur, M. Anne, Iyer, S. N., et Roy, M. - A., « [Family Approaches in Early Intervention: Benchmarks to Guide Intervention and Support Families in First Episode Psychosis Programs (FEPP)]. », Sante Ment Que, vol. 46, nᵒ 2, p. 139-159, 2021.
M. - A. Roy, Olivier, D., et Cambon, A., « [From Kraepelin to McGorry: Scientific Vision and Experiential Narrative around a Major Paradigmatic Shift]. », Sante Ment Que, vol. 46, nᵒ 2, p. 23-43, 2021.
A. Jérôme Romain, Bernard, P., Piché, F., Kern, L., Ouellet-Plamondon, C., Abdel-Baki, A., et Roy, M. - A., « [A Healthy Mind in a Healthy Body: The Value of Physical Activity for Youth With First Episode Psychosis]. », Sante Ment Que, vol. 46, nᵒ 2, p. 249-276, 2021.
O. Corbeil, Corbeil, S., Dorval, M., Carmichael, P. - H., Giroux, I., Jacques, C., Demers, M. - F., et M-A Roy, « Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program. », CNS Drugs, vol. 35, nᵒ 4, p. 461-468, 2021.
L. Béchard, Corbeil, O., Malenfant, E., Lehoux, C., Stip, E., Roy, M. - A., et Demers, M. - F., « [Psychopharmacology of First Episode Psychosis: An Approach Based on Recovery]. », Sante Ment Que, vol. 46, nᵒ 2, p. 113-137, 2021.
A. Lesage, Courteau, J., Brodeur, S., Stip, E., Fleury, M. - J., Courteau, M., M-A Roy, et Vanasse, A., « Urbanicity, Schizophrenia and Equitable Specialist Services Allocation. », Can J Psychiatry, p. 7067437211040606, 2021.
M. - A. Nolin, Demers, M. - F., Rauzier, C., Bouchard, R. - H., Cadrin, C., Després, J. - P., M-A Roy, Alméras, N., et Picard, F., « Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychotics. », World J Biol Psychiatry, p. 1-8, 2020.
M-A Roy, « The Evolution of Long-Acting Antipsychotics Use in Québec between 2003 and 2017. », Can J Psychiatry, vol. 65, nᵒ 7, p. 510-511, 2020.
E. Stip, Grignon, S., M-A Roy, Bloom, D., Osman, O., Amiri, L., Aziz, K. Abdul, Javaid, S. Fahad, et Arnone, D., « From QAAPAPLE 1 to QAAPAPLE 2: How do we move from one algorithm to another one with Long acting antipsychotics (LAIs). », Expert Rev Neurother, 2020.
P. Gagnon, Gaudreau, J. - D., M-A Roy, et Moreau, J. Le Moignan, « Letter to the Editor: Correction About the Nursing Delirium Screening Scale in Response to: "A Study of the Psychometric Properties of the "Stanford Proxy Test for Delirium" (S-PTD): A New Screening Tool for the Detection of Delirium". », Psychosomatics, 2020.
Y. C. Chagnon, Maziade, M., Paccalet, T., Croteau, J., Fournier, A., M-A Roy, et Bureau, A., « A multimodal attempt to follow-up linkage regions using RNA expression, SNPs and CpG methylation in schizophrenia and bipolar disorder kindreds. », Eur J Hum Genet, vol. 28, nᵒ 4, p. 499-507, 2020.
W. Pothier, M-A Roy, Corbière, M., Thibaudeau, É., Achim, A., Wykes, T., Reeder, C., Chagnon, Y., et Cellard, C., « Personalized cognitive remediation therapy to facilitate return to work or to school in recent-onset psychosis. », Neurocase, vol. 26, nᵒ 6, p. 340-352, 2020.
O. Corbeil, Corbeil, S., Giroux, I., Jacques, C., Dorval, M., Demers, M. - F., et M-A Roy, « Problem Gambling Associated With Aripiprazole in First-Episode Psychosis Patients: A Series of 6 Case Reports. », J Clin Psychopharmacol, vol. 40, nᵒ 2, p. 191-194, 2020.
V. Ferraro, Lafrenière, S., Demers, M. - F., M-A Roy, et Abdel-Baki, A., « "Real world" clinical effectiveness of paliperidone palmitate 3-monthly injectable in early psychosis patients. », Psychopharmacology (Berl), 2020.

Financement / Soutien / Partenaires

logo FRQ-S logo ctrn logo fci logo cihr irsc logo nserc logo MESISentinelle nord